YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Pang-Dian Fan, Giuseppe Narzisi, Anitha Jayaprakash, Elisa Venturini, Nicolas Robine, Peter Smibert, Soren Germer, Emmet Jordan, Lu Wang, Achim A Jungbluth, Lee Spraggon, Christine Marie Lovly, Mark G. Kris, Helena Alexandra Yu, Gregory J. Riely, Harold Varmus, Katerina A. Politi, Marc Ladanyi
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2885899129